Taxus Cardium Pharmaceuticals Group Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.29 |
Market Cap |
$2 M |
Shares Outstanding |
14.37 M |
Public Float |
12.77 M |
Address |
11750 Sorrento Valley Road San Diego California 92121 United States |
Employees | - |
Website | http://www.cardiumthx.com |
Updated | 07/08/2019 |
Taxus Cardium Pharmaceuticals Group, Inc. is regenerative therapeutics company . The company focuses on the late-stage clinical and development of regenerative medicine therapeutics. Its product candidates include Generx, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of cardiac microvascular insufficiency due to increasing coronary artery disease; and Excellagen, an acellular biological skin substitute designed as a wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers. |